Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,208Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Tasigna

PharmaCompass

01

Brand Name : Tasigna

Nilotinib

arrow
FCE Pharma
Not Confirmed

02

Brand Name : Tasigna

Nilotinib

arrow
FCE Pharma
Not Confirmed

03

Brand Name : Tasigna

Nilotinib

arrow
FCE Pharma
Not Confirmed

Brand Name : Tasigna

arrow
FCE Pharma
Not Confirmed

Nilotinib

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 1,923

2021 Revenue in Millions : 2,060

Growth (%) : -7

blank

04

Brand Name : Tasigna

Nilotinib

arrow
FCE Pharma
Not Confirmed

Brand Name : Tasigna

arrow
FCE Pharma
Not Confirmed

Nilotinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,848

2022 Revenue in Millions : 1,923

Growth (%) : -4

blank

05

Brand Name : Tasigna

Nilotinib

arrow
FCE Pharma
Not Confirmed

Brand Name : Tasigna

arrow
FCE Pharma
Not Confirmed

Nilotinib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 1,671

2023 Revenue in Millions : 1,848

Growth (%) : -10

blank

06

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
FCE Pharma
Not Confirmed

07

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
FCE Pharma
Not Confirmed

08

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
FCE Pharma
Not Confirmed

09

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
FCE Pharma
Not Confirmed

10

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
FCE Pharma
Not Confirmed